Shigeki Sekine
Shigeki Sekine publishes mostly in Oncology, Surgery and Pulmonary and Respiratory Medicine, on topics such as Gastric Cancer Management and Outcomes, Genetic factors in colorectal cancer and Esophageal Cancer Research and Treatment.
- World rank
- #256,936 of 7,710,434 ranked researchers
- Rank in Japan
- #2,062 of 383,136
- Works
- 337
- Citations
- 11k
- Citations per work
- 31.9
What does Shigeki Sekine research?
Shigeki Sekine's work is mostly in Medicine (69%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences23268.9%
- Medicine23268.9%
- Everything else7522.3%
- Life Sciences308.8%
- 1Oncology21% of their works
- 2Surgery17% of their works
- 3Pulmonary and Respiratory Medicine17% of their works
- 4Pathology and Forensic Medicine9% of their works
- 5Molecular Biology9% of their works
- 6Gastroenterology5% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Genetic factors in colorectal cancer
- Esophageal Cancer Research and Treatment
- Colorectal Cancer Screening and Detection
- Gastrointestinal Tumor Research and Treatment
- Metastasis and carcinoma case studies
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
Which keywords describe Shigeki Sekine's research?
The keywords of their largest research topics: Molecular Characterization, Endoscopic Resection, Chemotherapy, Clinical Practice Guidelines, Adjuvant Chemotherapy, Gastric Cancer, Lymph Node Dissection and Neoadjuvant Therapy.
- Laparoscopic Surgery
- Cetuximab
- Lung Tumors
- Imatinib Mesylate
- Colorectal Cancer
- Barrett's Esophagus
- Hereditary Syndromes
- Neoadjuvant Therapy
- Gastric Cancer
- Clinical Practice Guidelines
- Endoscopic Resection
- Molecular Characterization
- Chemotherapy
- Adjuvant Chemotherapy
- Lymph Node Dissection
- Preoperative Chemoradiotherapy
- Microsatellite Instability
- Esophageal Carcinoma
- Screening
- Sunitinib
- Metastatic Carcinomas
- KRAS Mutations
- Rectal Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Molecular Characterization1392 topics
- Endoscopic Resection1252 topics
- Chemotherapy1062 topics
- Clinical Practice Guidelines1062 topics
- Adjuvant Chemotherapy852 topics
- Gastric Cancer801 topic
- Lymph Node Dissection801 topic
- Neoadjuvant Therapy712 topics
- Preoperative Chemoradiotherapy712 topics
- Hereditary Syndromes591 topic
- Microsatellite Instability591 topic
- Barrett's Esophagus451 topic
- Esophageal Carcinoma451 topic
- Colorectal Cancer441 topic
- Screening441 topic
- Imatinib Mesylate401 topic
- Sunitinib401 topic
- Lung Tumors321 topic
- Metastatic Carcinomas321 topic
- Cetuximab261 topic
- KRAS Mutations261 topic
- Laparoscopic Surgery261 topic
- Rectal Cancer261 topic
Where does Shigeki Sekine work?
Shigeki Sekine's main affiliation in the publication record is Tokyo National Hospital, Japan.
How many publications and citations does Shigeki Sekine have?
OpenAlex counts 337 works and 10,747 citations for Shigeki Sekine, an h-index of 59, ranking #256,936 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Shigeki Sekine. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.